Treatment of coronary artery disease in hemodialysis patients: PTCA vs. stent

被引:12
作者
Malanuk, RM [1 ]
Nielsen, CD [1 ]
Theis, P [1 ]
Assey, ME [1 ]
Usher, BW [1 ]
Leman, RB [1 ]
机构
[1] Med Univ S Carolina, Dept Internal Med, Div Cardiol, Charleston, SC 29425 USA
关键词
hemodialysis; coronary angioplasty; coronary stenting;
D O I
10.1002/ccd.1311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This retrospective study examined the utilization of coronary stent placement versus PTCA in hemodialysis patients with obstructive coronary disease. Prior studies have demonstrated suboptimal results with PTCA owing primarily to high rates of restenosis. We identified 19 hemodialysis patients who received a percutaneous coronary intervention who were matched with individuals without renal failure undergoing same vessel revascularization. Our study found that 71% of hemodialysis patients receiving PTCA had a recurrent cardiac event defined by subsequent angina, myocardial infarction, or cardiac death. At follow-up, 30% of patients who received stent placement had recurrent cardiac events. Intracoronary stent placement is both safe and feasible and produces more favorable clinical outcomes in the management of coronary disease in hemodialysis patients. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 22 条
[1]   COMPLICATIONS AND LONG-TERM OUTCOME AFTER PERCUTANEOUS CORONARY ANGIOPLASTY IN CHRONIC-HEMODIALYSIS PATIENTS [J].
AHMED, WH ;
SHUBROOKS, SJ ;
GIBSON, CM ;
BAIM, DS ;
BITTL, JA .
AMERICAN HEART JOURNAL, 1994, 128 (02) :252-255
[2]  
Becker BN, 1997, J AM SOC NEPHROL, V8, P475
[3]  
CELEMAJER DS, 1997, J AM COLL CARDIOL, V39, P237
[4]  
deLemos JA, 1996, J AM SOC NEPHROL, V7, P2044
[5]   Mechanisms of disease - Antioxidants and atherosclerotic heart disease [J].
Diaz, MN ;
Frei, B ;
Vita, JA ;
Keaney, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :408-416
[6]   MEASUREMENT AND CONTROL IN THE PROCESS INDUSTRIES - EDITORIAL VIEWPOINT [J].
FISHER, TG .
ISA TRANSACTIONS, 1994, 33 (01) :1-2
[7]   CORONARY-ARTERY SURGERY IN PATIENTS WITH END-STAGE RENAL-DISEASE [J].
FRANCIS, GS ;
SHARMA, B ;
COLLINS, AJ ;
HELSETH, HK ;
COMTY, CM .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (04) :499-503
[8]  
HaagWeber M, 1996, SEMIN NEPHROL, V16, P192
[9]  
Hang CL, 1999, CATHETER CARDIO INTE, V47, P430, DOI 10.1002/(SICI)1522-726X(199908)47:4<430::AID-CCD10>3.3.CO
[10]  
2-T